Bioanalytical Systems to Expand Service Offerings
Bioanalytical Systems to Expand Service Offerings
DJ Bioanalytical Systems to Expand Service Offerings
DJ生物分析系統公司將擴大服務範圍
By Michael Dabaie
邁克爾·達拜(Michael Dabaie)著
Bioanalytical Systems Inc. said Wednesday it plans to expand its service offerings to add cardiovascular safety pharmacology capabilities.
生物分析系統公司(BioAnalytic Systems Inc.)週三表示，計劃擴大服務範圍，增加心血管安全藥理學能力。
The provider of nonclinical and analytical contract research services, which does business as Inotiv, said it plans to add cardiovascular safety pharmacology capabilities to its existing capabilities for respiratory and central nervous system safety pharmacology.
這家非臨牀和分析合同研究服務提供商的業務名稱為Inov，該公司表示，計劃在現有的呼吸和中樞神經系統安全藥理學能力的基礎上增加心血管安全藥理學能力。
Safety pharmacology evaluations are critical for assessing the effect of drug candidates, the company said.
該公司表示，安全藥理學評估對於評估候選藥物的效果至關重要。
Inotiv said that by summer 2021 it expects to offer integrated safety pharmacology packages that include core battery tests for cardiovascular, respiratory, and central nervous system functions as standalone safety pharmacology packages or as part of a full investigational new drug/clinical trial application program.
INotiv表示，預計到2021年夏天，它將提供集成的安全藥理包，其中包括心血管、呼吸和中樞神經系統功能的核心電池測試，作為獨立的安全藥理包，或作為全面的調查性新葯/臨牀試驗應用計劃的一部分。
The company previously relied on subcontractors for these cardiovascular assessments.
該公司之前依賴分包商進行這些心血管評估。
"Over the past year, we've made significant investments towards reducing our subcontracted and outsourced work," said Chief Executive Robert Leasure Jr. "This is a continuation of that strategy that we believe will allow us to improve speed and control quality of services while also enhancing margins."
首席執行官小羅伯特·萊蘇爾(Robert Leasure Jr.)表示：“在過去的一年裏，我們在減少分包和外包工作方面進行了重大投資。”這是這一戰略的延續，我們相信這將使我們能夠提高速度和控制服務質量，同時提高利潤率。“
Write to Michael Dabaie at michael.dabaie@wsj.com
寫信給Michael Dabaie，電子郵件：michael.dabaie@wsj.com
(END) Dow Jones Newswires
(完)道瓊通訊社
March 17, 2021 09:08 ET (13:08 GMT)
2021年3月17日09：08美國東部時間(格林尼治標準時間13：08)
Copyright (c) 2021 Dow Jones & Company, Inc.
版權所有(C)2021年道瓊斯公司
譯文內容由第三人軟體翻譯。